Key result
Patients with pulmonary arterial hypertension exhibited a high rate of abnormal microvolt T-wave alternans (73%), which was similar to the rate observed in patients with left ventricular dysfunction.
Why the study?
Does the profile of microvolt T-wave alternans differ between patients with pulmonary arterial hypertension, left ventricular dysfunction, and healthy volunteers?
Observational (n=74)
Does the profile of microvolt T-wave alternans differ between patients with pulmonary arterial hypertension, left ventricular dysfunction, and healthy volunteers?
Patients with pulmonary arterial hypertension exhibit a high rate of microvolt T-wave alternans abnormalities comparable to patients with left ventricular dysfunction, suggesting a potential role for MTWA in sudden cardiac death risk stratification in this population.
Abnormal MTWA rates in PAH match those in LV dysfunction; hypothesis-generating for SCD risk stratification and should not yet change practice.
OBJECTIVE: Microvolt T-wave alternans (MTWA) is a well-examined parameter for the risk stratification of sudden cardiac death (SCD) in patients with left ventricular dysfunction (LVD). However, the role of MTWA in pulmonary arterial hypertension (PAH) remains obscure. Consequently, the present study aimed to analyze the profile of MTWA among PAH patients in comparison with LVD patients and healthy volunteers. METHODS: The prospectively study included 22 patients with PAH (mean pulmonary artery pressure ≥ 25 mm Hg and pulmonary capillary wedge pressure ≤15 mm Hg during right heart catheterization; mean age, 40±17 years); 24 with LVD [left ventricular ejection fraction (LVEF) ≤35%; mean age, 40±11 years]; and 28 healthy volunteers (mean age, 41±8 years). Patients with persistent atrial arrhythmia were excluded. The MTWA (spectral method) categories were positive, negative, or indeterminate (MTWA_pos, MTWA_neg, or MTWA_ind, respectively). MTWA_pos and MTWA_ind were qualified as abnormal (MTWA_abn). Statistical analyses (Mann-Whitney U, chi-square with Yates's correction, Fisher's exact test) were performed. RESULTS: PAH patients had higher LVEF than LVD patients (61±7% vs. 27±7%; p<0.05). MTWA_abn was observed more frequently in the PAH and LVD groups than in the healthy volunteers. Patients with PAH were characterized by a considerable percentage of MTWA_pos and MTWA_abn (59% and 73%, respectively), but this did not differ from LVD patients. CONCLUSION: Patients with PAH are characterized by a high rate of MTWA abnormalities similar to LVD patients, despite the relevant differences in LVEF. Further research is required to elucidate the clinical significance and prognostic value of this data, particularly in the context of SCDunderlying mechanisms in PAH patients.
No takes yet. Share an insight, caveat, or question.
Ludmiła Daniłowicz‐Szymanowicz (2016) conducted an observational in Pulmonary arterial hypertension (n=74). Pulmonary arterial hypertension vs. Left ventricular dysfunction and healthy volunteers was evaluated on Abnormal microvolt T-wave alternans (MTWA_abn). Patients with pulmonary arterial hypertension exhibited a high rate of abnormal microvolt T-wave alternans (73%), which was similar to the rate observed in patients with left ventricular dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: